IndraLab

Statements


P5091 inhibits NEK2 protein. 1 / 1
| 1

eidos
"It has recently been revealed that P5091 , a nonreversible USP7 inhibitor , can deplete NEK2 protein in vitro and in vivo , resulting in suppression of NEK2 downstream target , thus overcoming bortezomib resistance ( 98 ) ."